Table 2.
Distribution of Patients in Each Group by Stage and 10-year Survival Rate. And Expected Additional Deaths
| Non-pandemic |
Pandemic |
The 10-year Survival Rate (%) (The Relative Values) | |||
|---|---|---|---|---|---|
| n=296 | % | n=249 | % | ||
| Stage Ⅰ | 137 | 46.3 | 108 | 43.4 | 98.0 |
| Stage Ⅱ | 117 | 40.0 | 93 | 37.3 | 88.4 |
| Stage Ⅲ | 32 | 10.8 | 26 | 10.4 | 63.8 |
| Stage Ⅳ | 10 | 3.4 | 22 | 8.8 | 19.2 |
| Total | 296 | 100.0 | 249 | 100.0 | 86.8 |
| The weighted average | 0.8785(SE=0.0164) | 0.8388(SE=0.0184) | |||
| Difference in survival rate | 3.96points (95%CI: -0.87—8.80 P>0.05) | ||||
| Expected increase in number of deaths | 2134 (-470−4738) | ||||